Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 76 entries
View as:

Interest in Electronic Applications for Patients With Glaucoma

Phase: N/A Priority: Normal
NCT ID: NCT02659709 Org: User:
Start: 06/30/15 End: 10/31/16 Due: 10/31/17

IOP and Medication Reduction in MIGS Procedures

Phase: N/A Priority: Normal
NCT ID: NCT04202510 Org: User:
Start: 01/06/20 End: 11/12/20 Due: 11/12/21

Handheld Vibrator Versus Topical Eye Drops as Anesthesia for Intravitreal Injections

Phase: N/A Priority: Normal
NCT ID: NCT03079713 Org: User:
Start: 04/12/17 End: 03/20/19 Due: 03/20/20

A Proposed Intervention to Decrease Resident-Performed Cataract Surgery Cancellation

Phase: N/A Priority: Normal
NCT ID: NCT02621840 Org: User:
Start: 01/31/15 End: 12/31/15 Due: 12/31/16

Isotretinoin for Proliferative Vitreoretinopathy

Phase: N/A Priority: Normal
NCT ID: NCT01445028 Org: User:
Start: 09/30/11 End: 08/31/15 Due: 08/31/16

Does Glaucoma Cause Loss of Brain Function?

Phase: N/A Priority: Normal
NCT ID: NCT01303939 Org: User:
Start: 08/31/10 End: 08/31/13 Due: 08/31/14

Community Glaucoma Screening Follow-up

Phase: N/A Priority: Normal
NCT ID: NCT00956865 Org: User:
Start: 09/30/02 End: 09/30/02 Due: 09/30/03

Transcorneal Electrical Stimulation (TES) for the Treatment of Amblyopia

Phase: N/A Priority: Normal
NCT ID: NCT02495935 Org: User:
Start: 07/31/15 End: 08/31/20 Due: 08/31/21

Overcoming Barriers in Vision Care Utilization of African Americans With Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01744132 Org: User:
Start: 10/31/12 End: 10/31/16 Due: 10/31/17

Using a Type of Blue Dye to Observe Bleb Function During Cataract Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02526706 Org: User:
Start: 08/31/15 End: 10/31/16 Due: 10/31/17

Is the RAPDx Pupillograph Able to Distinguish Between Glaucoma Subjects and Healthy Subjects?

Phase: N/A Priority: Normal
NCT ID: NCT02526693 Org: User:
Start: 06/30/14 End: 08/31/15 Due: 08/31/16

Social Worker in an Eye-Care Service

Phase: N/A Priority: Normal
NCT ID: NCT03304535 Org: User:
Start: 01/31/16 End: 08/31/17 Due: 08/31/18

Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?

Phase: N/A Priority: Normal
NCT ID: NCT00405431 Org: User:
Start: 03/31/04 End: 11/30/07 Due: 11/30/08

How Similar Are Changes to the Surface of the Eye When Two Different Glaucoma Eye Drops Are Used?

Phase: N/A Priority: Normal
NCT ID: NCT00798694 Org: User:
Start: 11/30/08 End: 02/28/11 Due: 02/28/12

Heidelberg Edge Perimetry (HEP) Detecting Glaucomatous Visual Field Defects

Phase: N/A Priority: Normal
NCT ID: NCT02526654 Org: User:
Start: 12/31/14 End: 07/31/15 Due: 07/31/16

Comparing SD-tVEP and PERG Tests Between Patients With Glaucoma, Patients With High Eye Pressure and "Normal" Patients

Phase: N/A Priority: Normal
NCT ID: NCT02604953 Org: User:
Start: 07/31/14 End: 07/31/15 Due: 07/31/16

A Study of the Effectiveness of a Local Injection of Chemotherapy for Retinoblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00857519 Org: User:
Start: 01/31/09 End: 04/30/14 Due: 04/30/15

Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa - a Safety and Efficacy Multicenter Study

Phase: N/A Priority: Normal
NCT ID: NCT02548572 Org: User:
Start: 01/31/19 End: 12/31/20 Due: 12/31/21

Eplerenone for the Treatment of Central Serous Chorioretinopathy

Phase: N/A Priority: Normal
NCT ID: NCT01990677 Org: User:
Start: 10/31/13 End: 05/31/15 Due: 05/31/16

Water Drinking Test in Patients With Occludable Angle

Phase: N/A Priority: Normal
NCT ID: NCT02613533 Org: User:
Start: 02/28/10 End: 01/31/15 Due: 01/31/16

A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR

Phase: N/A Priority: Normal
NCT ID: NCT05660447 Org: User:
Start: 02/06/23 End: 01/31/25 Due: 01/31/26

Caffeine Consumption in Glaucoma Patients and Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03675412 Org: User:
Start: 12/30/18 End: 12/31/25 Due: 12/31/26

Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study

Phase: N/A Priority: Normal
NCT ID: NCT03323164 Org: User:
Start: 07/10/17 End: 05/30/20 Due: 05/30/21

Educational Intervention to Adopt SLT as First-Line Glaucoma Treatment

Phase: N/A Priority: Normal
NCT ID: NCT03365778 Org: User:
Start: 10/23/17 End: 12/31/19 Due: 12/31/20

RETINA IMPLANT Alpha AMS in Blind Patients With Retinitis Pigmentosa

Phase: N/A Priority: Normal
NCT ID: NCT03629899 Org: User:
Start: 03/31/19 End: 07/31/25 Due: 07/31/26